Casgevy (exagamglogene autotemcel) and Lyfgenia (lovotibeglogene autotemcel) for individuals 12 years and older with sickle cell disease (SCD) and recurrent vaso-occlusive crises (VOC): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)

Lesmana, H., Kim, S. Y., Corado, A. M., & Poskanzer, S. A. (2024). Casgevy (exagamglogene autotemcel) and Lyfgenia (lovotibeglogene autotemcel) for individuals 12 years and older with sickle cell disease (SCD) and recurrent vaso-occlusive crises (VOC): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine Open, 2, 101875. https://doi.org/10.1016/j.gimo.2024.101875

Authors:

Harry Lesmana

Sun Young Kim

Andrés Morales Corado

Sheri A Poskanzer

Affiliated Authors:

Andrés Morales Corado

Columbia Affiliation: